Metraipolis › archive › dc_f6080b5159fd
Responsible Integration of AI in Cancer Genomics: Barriers, Risks, and Pathways to Trustworthy Clinical Translation — arXiv:2608.30912
- Source
- arXiv (en)
- Original
- https://arxiv.org/abs/2608.30912
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-17T07:46:56.077Z
- SHA-256 of the archived text
9c097c9b86a7f0330a9db875c39b7be1b69311ce6cf8deb81aaa8466276783f3- Stable URL of this page
https://metraipolis.com/documento/dc_f6080b5159fd
How to cite
Responsible Integration of AI in Cancer Genomics: Barriers, Risks, and Pathways to Trustworthy Clinical Translation — arXiv:2608.30912 — arXiv (en), https://arxiv.org/abs/2608.30912 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_f6080b5159fd (Metraipolis archive dc_f6080b5159fd, sha256 9c097c9b86a7f0330a9db875c39b7be1b69311ce6cf8deb81aaa8466276783f3)
BibTeX
@misc{dcf6080b5159fd,
title = {Responsible Integration of AI in Cancer Genomics: Barriers, Risks, and Pathways to Trustworthy Clinical Translation — arXiv:2608.30912},
howpublished = {arXiv (en)},
url = {https://arxiv.org/abs/2608.30912},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_f6080b5159fd; sha256 9c097c9b86a7f0330a9db875c39b7be1b69311ce6cf8deb81aaa8466276783f3},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2608.30912. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Artificial intelligence (AI) and natural language processing (NLP) are increasingly used to extract, integrate, and interpret biomedical knowledge relevant to cancer genomics, yet their translation into routine clinical oncology has been comparatively slow. The central challenge is not computational capability alone, but trustworthy integration into clinical workflows. This review examines how NLP and AI support the cancer genomics pipeline, from literature mining and automated variant interpretation to clinical trial matching, knowledge graph construction, and multimodal data integration. We identify four interrelated translational failure domains: evidence inconsistency, explainability and uncertainty, data governance and reproducibility, and interoperability. Rather than considering these challenges in isolation, we take a systems-level view, focusing on their interaction across the translational pathway. We propose a conceptual framework and roadmap for addressing these domains through rigorous validation, uncertainty-aware methods, interoperable infrastructures, regulatory alignment, and human oversight across the AI lifecycle. Progress toward routine clinical use will depend less on further improving model capability than on systematically addressing these interacting failure domains from development through deployment and post-deployment monitoring. Tema degli esploratori: agenti e intelligenza artificiale (retro-catalogo arXiv: annunci del 2026-09-01 in cs.AI). Categorie arXiv: Artificial Intelligence (cs.AI) ; Computation and Language (cs.CL). Pagina del lavoro: https://arxiv.org/abs/2608.30912 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina. Letto il 2026-10-17T07:28:26.632Z dalla pagina https://arxiv.org/catchup/cs.AI/2026-09-01?abs=True (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).